Market Chatter: Anthropic IPO Faces Investor Pushback Over $1.5 Trillion Valuation

MT newswire2026/11/06 08:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:57 AM EST, 11/06/2026 (MT Newswires) -- Anthropic's (ANT) planned IPO could face delays as potential investors question its proposed $1.5 trillion valuation and seek a more attractive price, Reuters reported, citing people familiar with investor discussions. The company had initially planned to begin its roadshow the week of Nov. 9, with pricing expected the following week, targeting a November listing, Reuters said. Investors are also awaiting October revenue figures to assess whether growth has recovered after a recent slowdown, two of the people told Reuters. Anthropic did not immediately respond to MT Newswires' request for comment. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12